» Articles » PMID: 12776867

Characterization of Sustained Atrial Tachycardia in Dogs with Rapid Ventricular Pacing-induced Heart Failure

Overview
Date 2003 Jun 5
PMID 12776867
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Atrial arrhythmias often complicate congestive heart failure (CHF). We characterized inducible atrial tachyarrhythmias and electrophysiologic alterations in dogs with CHF and atrial enlargement produced by rapid ventricular pacing.

Methods And Results: Endocardial pacing leads were implanted in the right ventricle, right atrium, and coronary sinus in 18 dogs. The right ventricular lead was connected to an implanted pacemaker capable of rapid ventricular pacing. The atrial leads were used to perform electrophysiologic studies in conscious animals at baseline in all dogs, during CHF induced by rapid ventricular pacing at 235 beats/min in 15 dogs, and during recovery from CHF in 6 dogs. After 20 +/- 7 days of rapid ventricular pacing, inducibility of sustained atrial tachycardia (cycle length 120 +/- 12 msec) was enhanced in dogs with CHF. Atrial tachycardia required a critical decrease in atrial burst pacing cycle length (< or = 130 msec) for induction and often could be terminated by overdrive pacing. Calcium antagonists (verapamil, flunarizine, ryanodine) terminated atrial tachycardia and suppressed inducibility. Effective refractory periods at 400- and 300-msec cycle lengths in the right atrium and coronary sinus were prolonged in dogs with CHF. Atrial cells from dogs with CHF had prolonged action potential durations and reduced resting potentials and delayed afterdepolarizations (DADs). Mitochondria from atrial tissue from dogs with CHF were enlarged and had internal cristae disorganization.

Conclusions: CHF promotes inducibility of sustained atrial tachycardia. Based on the mode of tachycardia induction, responses to pacing and calcium antagonists, and presence of DADs, atrial tachycardia in this CHF model has a mechanism most consistent with DAD-induced triggered activity resulting from intracellular calcium overload.

Citing Articles

Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease.

Jansen H, Bohne L, Gillis A, Rose R Heart Rhythm O2. 2021; 1(2):147-159.

PMID: 34113869 PMC: 8183954. DOI: 10.1016/j.hroo.2020.05.002.


Meta-analysis of the Usefulness of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction.

Aldaas O, Lupercio F, Darden D, Mylavarapu P, Malladi C, Han F Am J Cardiol. 2020; 142:66-73.

PMID: 33290688 PMC: 7902199. DOI: 10.1016/j.amjcard.2020.11.039.


Investigational Anti-Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?.

Burashnikov A J Cardiovasc Pharmacol. 2020; 76(5):492-505.

PMID: 33165131 PMC: 7641178. DOI: 10.1097/FJC.0000000000000892.


Afterdepolarizations and abnormal calcium handling in atrial myocytes with modulated SERCA uptake: a sensitivity analysis of calcium handling channels.

Lo A, Bai J, Gladding P, Fedorov V, Zhao J Philos Trans A Math Phys Eng Sci. 2020; 378(2173):20190557.

PMID: 32448059 PMC: 7287332. DOI: 10.1098/rsta.2019.0557.


Loss of myeloid differentiation protein 1 promotes atrial fibrillation in heart failure with preserved ejection fraction.

Shuai W, Kong B, Yang H, Fu H, Huang H ESC Heart Fail. 2020; 7(2):626-638.

PMID: 31994333 PMC: 7160510. DOI: 10.1002/ehf2.12620.